...
首页> 外文期刊>Neuropeptides: An International Journal >Microinjection of cocaine- and amphetamine-regulated transcript 55-102 peptide into the nucleus accumbens could modulate anxiety-related behavior in rats
【24h】

Microinjection of cocaine- and amphetamine-regulated transcript 55-102 peptide into the nucleus accumbens could modulate anxiety-related behavior in rats

机译:将可卡因和苯丙胺调节的转录本55-102肽微注射到伏隔核中可以调节大鼠的焦虑相关行为

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Cocaine- and amphetamine-regulated transcript (CART) peptide is abundantly expressed in the nucleus accumbens (NAcc) and is involved in stress, anxiety and reward responses. To examine the role of CART peptide in anxiety-related behavior, nave rats were bilaterally injected with CART 55-102 peptide (0.5, 1.0 or 2.5 mu g/0.5 mu l/side) or vehicle into the NAcc. Following this, their anxiety-related behavior was assessed using the elevated plus maze and the open field tests with a one-week interval between the tests. There was no difference in the time spent in open arms, or number of entries into open arms on the elevated plus maze in the CART-treated animals at any dose, when compared with the vehicle-treated group. However, there was a significant increase in the time spent in the center of the open field with administration of the low dose of CART peptide (0.5 mu g/0.5 mu l/side), although this effect disappeared at the high dose (2.5 mu g/0.5 mu l/side). None of the doses of CART peptide altered total locomotion in these tests. To further determine the possible anxiety-modulating effect of CART peptide at low dosages, the light and dark test was performed. Additional groups of rats given doses of 0.01 mu g/0.5 mu l/side or 0.5 mu g/0.5 mu l/side of CART peptide showed increased exploration time in the light side. These results suggest that accumbal-CART peptide reduces anxiety-like behavior in a dose-dependent manner. (C) 2014 Elsevier Ltd. All rights reserved.
机译:可卡因和苯丙胺调节的转录物(CART)肽在伏伏核(NAcc)中大量表达,并参与应激,焦虑和奖赏反应。为了检查CART肽在与焦虑相关的行为中的作用,将NAC中的未成年大鼠双侧注射CART 55-102肽(0.5、1.0或2.5μg/0.5μl/侧)或赋形剂。此后,使用高架迷宫和开放式田间试验评估他们与焦虑相关的行为,两次试验之间的间隔为一周。与溶媒治疗组相比,在任何剂量下,接受CART治疗的动物在张开双臂上花费的时间,或进入高架迷宫中张开双臂的次数均无差异。但是,尽管低剂量的CART肽(0.5μg / 0.5μl/侧)给药,在旷野中心花费的时间显着增加,尽管这种效应在高剂量(2.5μg/ min)下消失了。 g / 0.5升/面)。在这些测试中,CART肽的剂量均未改变总运动。为了进一步确定低剂量CART肽可能产生的焦虑调节作用,进行了明暗测试。给予0.01μg / 0.5μl/边或0.5μg / 0.5μl/边的CART肽剂量的其他组的大鼠,在较亮侧的探索时间增加。这些结果表明,AccuBal-CART肽以剂量依赖性方式降低了焦虑样行为。 (C)2014 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号